February 15, 2022 / 13:12 IST
Reported Consolidated quarterly numbers for Panacea Biotec are:Net Sales at Rs 155.88 crore in December 2021 up 9.96% from Rs. 141.76 crore in December 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 49.20 crore in December 2021 down 22.85% from Rs. 40.05 crore in December 2020.
EBITDA stands at Rs. 13.52 crore in December 2021 down 20.66% from Rs. 17.04 crore in December 2020.
Panacea Biotec shares closed at 195.50 on February 14, 2022 (NSE) and has given -38.92% returns over the last 6 months and -5.10% over the last 12 months.
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 155.88 | 232.17 | 141.76 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 155.88 | 232.17 | 141.76 | | EXPENDITURE | | Consumption of Raw Materials | 43.05 | 141.32 | 50.31 | | Purchase of Traded Goods | 7.72 | 5.92 | 2.50 | | Increase/Decrease in Stocks | -4.18 | -43.36 | -10.30 | | Power & Fuel | -- | -- | -- | | Employees Cost | 45.67 | 45.73 | 39.17 | | Depreciation | 10.55 | 10.90 | 11.31 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 51.76 | 76.54 | 44.93 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 1.31 | -4.88 | 3.84 | | Other Income | 1.66 | 2.03 | 1.89 | | P/L Before Int., Excpt. Items & Tax | 2.97 | -2.85 | 5.73 | | Interest | 52.13 | 50.16 | 45.69 | | P/L Before Exceptional Items & Tax | -49.16 | -53.01 | -39.96 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -49.16 | -53.01 | -39.96 | | Tax | 0.04 | -- | 0.04 | | P/L After Tax from Ordinary Activities | -49.20 | -53.01 | -40.00 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -49.20 | -53.01 | -40.00 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -0.05 | | Net P/L After M.I & Associates | -49.20 | -53.01 | -40.05 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -8.03 | -8.65 | -6.54 | | Diluted EPS | -8.03 | -8.65 | -6.54 | | EPS After Extra Ordinary | | Basic EPS | -8.03 | -8.65 | -6.54 | | Diluted EPS | -8.03 | -8.65 | -6.54 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
